vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and Navitas Semiconductor Corp (NVTS). Click either name above to swap in a different company.
Gossamer Bio, Inc. is the larger business by last-quarter revenue ($13.8M vs $7.3M, roughly 1.9× Navitas Semiconductor Corp). Gossamer Bio, Inc. runs the higher net margin — -342.3% vs -436.1%, a 93.7% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs -59.4%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
Navitas Semiconductor Corp is a leading global semiconductor firm specializing in gallium nitride (GaN) power integrated circuits. Its high-efficiency, compact power solutions serve consumer electronics, electric vehicles, renewable energy, and industrial sectors, with clients spanning North America, Asia, and Europe.
GOSS vs NVTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $7.3M |
| Net Profit | $-47.2M | $-31.8M |
| Gross Margin | — | 38.1% |
| Operating Margin | -333.6% | -567.3% |
| Net Margin | -342.3% | -436.1% |
| Revenue YoY | 47.1% | -59.4% |
| Net Profit YoY | -43.0% | 20.2% |
| EPS (diluted) | $-0.21 | $-0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $7.3M | ||
| Q3 25 | $13.3M | $10.1M | ||
| Q2 25 | — | $14.5M | ||
| Q1 25 | — | $14.0M | ||
| Q4 24 | — | $18.0M | ||
| Q3 24 | — | $21.7M | ||
| Q2 24 | $95.8M | $20.5M | ||
| Q1 24 | $0 | $23.2M |
| Q4 25 | $-47.2M | $-31.8M | ||
| Q3 25 | $-48.2M | $-19.2M | ||
| Q2 25 | — | $-49.1M | ||
| Q1 25 | — | $-16.8M | ||
| Q4 24 | — | $-39.9M | ||
| Q3 24 | — | $-18.7M | ||
| Q2 24 | $49.2M | $-22.3M | ||
| Q1 24 | $-41.9M | $-3.7M |
| Q4 25 | — | 38.1% | ||
| Q3 25 | — | 37.9% | ||
| Q2 25 | — | 16.1% | ||
| Q1 25 | — | 37.9% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | — | 39.7% | ||
| Q2 24 | — | 39.0% | ||
| Q1 24 | — | 41.1% |
| Q4 25 | -333.6% | -567.3% | ||
| Q3 25 | -369.4% | -192.0% | ||
| Q2 25 | — | -149.4% | ||
| Q1 25 | — | -180.5% | ||
| Q4 24 | — | -216.9% | ||
| Q3 24 | — | -133.6% | ||
| Q2 24 | 54.3% | -152.1% | ||
| Q1 24 | — | -136.2% |
| Q4 25 | -342.3% | -436.1% | ||
| Q3 25 | -362.7% | -190.2% | ||
| Q2 25 | — | -338.7% | ||
| Q1 25 | — | -120.1% | ||
| Q4 24 | — | -221.7% | ||
| Q3 24 | — | -86.4% | ||
| Q2 24 | 51.4% | -109.1% | ||
| Q1 24 | — | -15.9% |
| Q4 25 | $-0.21 | $-0.14 | ||
| Q3 25 | $-0.21 | $-0.09 | ||
| Q2 25 | — | $-0.25 | ||
| Q1 25 | — | $-0.09 | ||
| Q4 24 | — | $-0.22 | ||
| Q3 24 | — | $-0.10 | ||
| Q2 24 | $0.22 | $-0.12 | ||
| Q1 24 | $-0.19 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $236.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-122.8M | $443.7M |
| Total Assets | $172.2M | $500.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | $236.9M | ||
| Q3 25 | $180.2M | $150.6M | ||
| Q2 25 | — | $161.2M | ||
| Q1 25 | — | $75.1M | ||
| Q4 24 | — | $86.7M | ||
| Q3 24 | — | $98.3M | ||
| Q2 24 | $354.5M | $111.7M | ||
| Q1 24 | $244.4M | $128.9M |
| Q4 25 | $-122.8M | $443.7M | ||
| Q3 25 | $-82.3M | $371.0M | ||
| Q2 25 | — | $388.9M | ||
| Q1 25 | — | $341.8M | ||
| Q4 24 | — | $348.0M | ||
| Q3 24 | — | $380.8M | ||
| Q2 24 | $81.5M | $388.1M | ||
| Q1 24 | $26.7M | $397.9M |
| Q4 25 | $172.2M | $500.5M | ||
| Q3 25 | $208.8M | $430.2M | ||
| Q2 25 | — | $449.4M | ||
| Q1 25 | — | $370.8M | ||
| Q4 24 | — | $390.0M | ||
| Q3 24 | — | $419.4M | ||
| Q2 24 | $373.4M | $439.1M | ||
| Q1 24 | $259.4M | $467.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $-8.1M |
| Free Cash FlowOCF − Capex | — | $-8.2M |
| FCF MarginFCF / Revenue | — | -111.8% |
| Capex IntensityCapex / Revenue | 0.0% | 0.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-44.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | $-8.1M | ||
| Q3 25 | $-36.2M | $-10.0M | ||
| Q2 25 | — | $-11.2M | ||
| Q1 25 | — | $-13.5M | ||
| Q4 24 | — | $-10.2M | ||
| Q3 24 | — | $-13.7M | ||
| Q2 24 | $116.3M | $-15.1M | ||
| Q1 24 | $-52.3M | $-19.8M |
| Q4 25 | — | $-8.2M | ||
| Q3 25 | — | $-10.7M | ||
| Q2 25 | — | $-11.9M | ||
| Q1 25 | — | $-13.6M | ||
| Q4 24 | — | $-10.8M | ||
| Q3 24 | — | $-14.3M | ||
| Q2 24 | — | $-17.9M | ||
| Q1 24 | — | $-22.7M |
| Q4 25 | — | -111.8% | ||
| Q3 25 | — | -106.1% | ||
| Q2 25 | — | -82.2% | ||
| Q1 25 | — | -96.8% | ||
| Q4 24 | — | -59.8% | ||
| Q3 24 | — | -65.9% | ||
| Q2 24 | — | -87.3% | ||
| Q1 24 | — | -97.9% |
| Q4 25 | 0.0% | 0.7% | ||
| Q3 25 | 0.0% | 7.0% | ||
| Q2 25 | — | 4.7% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | — | 2.6% | ||
| Q2 24 | 0.0% | 13.4% | ||
| Q1 24 | — | 12.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.36× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
